Injectable Drug Delivery Partnering 2010-2015 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the world's leading healthcare companies.
This report provides details of the latest Injectable Drug Delivery agreements announced in the life sciences since 2010.
The report takes the reader through a comprehensive review Injectable Drug Delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Injectable Drug Delivery partnering deals.
The report presents financial deal term values for Injectable Drug Delivery deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.
One of the key highlights of the report is that over 280 online deal records of actual Injectable Drug Delivery deals, as disclosed by the deal parties, are included towards the end of the report in a directory format- by company A-Z, stage of development, deal type, therapy focus, and technology type- that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.
Injectable Drug Delivery Partnering Terms and Agreements includes:
- Trends in Injectable Drug Delivery dealmaking in the biopharma industry since 2010
- Analysis of Injectable Drug Delivery deal structure
- Access to headline, upfront, milestone and royalty data
- Case studies of real-life Injectable Drug Delivery deals
- Access to Injectable Drug Delivery contract documents
- Leading Injectable Drug Delivery deals by value since 2010
- Most active Injectable Drug Delivery dealmakers since 2010
In Global Injectable Drug Delivery Partnering 2010-2016: Deal trends, players, financials and forecasts, the available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target
- Technology type
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Injectable Drug Delivery dealmaking
Chapter 3 - Leading Injectable Drug Delivery deals
Chapter 4 - Most active Injectable Drug Delivery dealmakers
Chapter 5 - Injectable Drug Delivery contracts dealmaking directory
Chapter 6 - Injectable Drug Delivery dealmaking by technology type
Chapter 7 - Partnering resource center
For more information about this report visit http://www.researchandmarkets.com/research/3kxqgj/global_injectable
Related Topics: Infusions and Injectables
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-injectable-drug-delivery-partnering-deal-trends-players--financials-by-the-worlds-largest-leading-healthcare-companies-2010-2016---research-and-markets-300322763.html
SOURCE Research and Markets